Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation. Q4 FY2025 (2025-12-31): -143.22.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-130.67
EARNINGS PER SHARE (EPS) AVG 3Y
-1084.61
EARNINGS PER SHARE (EPS) AVG 5Y
-489.21
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Zhongchao Inc.
Market Cap
$30389.00
Earnings Per Share (EPS)
N/A
TTM Avg
-130.67
3Y Avg
-1084.61
5Y Avg
-489.21
Market Cap
$29771.00
Earnings Per Share (EPS)
N/A
TTM Avg
-110.58
3Y Avg
-60.80
5Y Avg
-49.51
Market Cap
$6235.00
Earnings Per Share (EPS)
N/A
TTM Avg
-24.78
3Y Avg
156.25
5Y Avg
124.99
Market Cap
$61172.00
Earnings Per Share (EPS)
N/A
TTM Avg
-459.91
3Y Avg
-720819.96
5Y Avg
-483554.38
Market Cap
$70884.00
Earnings Per Share (EPS)
-11.16
TTM Avg
-405.74
3Y Avg
-2510.68
5Y Avg
-2758.31
Market Cap
$95475.00
Earnings Per Share (EPS)
N/A
TTM Avg
-5.39
3Y Avg
-4.78
5Y Avg
-3.78
Market Cap
$110112.00
Earnings Per Share (EPS)
-56.54
TTM Avg
-2021.61
3Y Avg
-2656.46
5Y Avg
-1785.38
Market Cap
$250443.00
Earnings Per Share (EPS)
N/A
TTM Avg
-446.18
3Y Avg
-284.47
5Y Avg
-299.57
Market Cap
$378849.00
Earnings Per Share (EPS)
N/A
TTM Avg
-30.82
3Y Avg
-68.47
5Y Avg
-54.27
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zhongchao Inc. (ZCMD) | $30389.00 | N/A | -130.67 | -1084.61 | -489.21 |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $29771.00 | N/A | -110.58 | -60.80 | -49.51 |
| NewGenIvf Group Limited (NIVF)vs › | $6235.00 | N/A | -24.78 | 156.25 | 124.99 |
| Akanda Corp. (AKAN)vs › | $61172.00 | N/A | -459.91 | -720819.96 | -483554.38 |
| PRF Technologies Ltd. (PRFX)vs › | $70884.00 | -11.16 | -405.74 | -2510.68 | -2758.31 |
| Psyence Biomedical Ltd. (PBM)vs › | $95475.00 | N/A | -5.39 | -4.78 | -3.78 |
| Silexion Therapeutics Ltd. (SLXN)vs › | $110112.00 | -56.54 | -2021.61 | -2656.46 | -1785.38 |
| SciSparc Ltd. (SPRC)vs › | $250443.00 | N/A | -446.18 | -284.47 | -299.57 |
| Virax Biolabs Group Limited (VRAX)vs › | $378849.00 | N/A | -30.82 | -68.47 | -54.27 |
| Niki BioSolutions, Inc. (NIKI)vs › | $403887.00 | N/A | -48.50 | -108.50 | -157.67 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -172.05 |
| 2024-12-31 | -89.28 |
| 2023-12-31 | -3236.40 |
| 2022-12-31 | -840.72 |
| 2021-12-31 | 71.42 |
| 2020-12-31 | 1331.76 |
| 2019-12-31 | 1175.52 |
| 2018-12-31 | 900.24 |
| 2017-12-31 | 453.84 |
